Progress of inflammatory cytokines as lymphoma biomarkers and molecular targets
10.3760/cma.j.issn.1009-9921.2019.08.012
- VernacularTitle:炎性细胞因子作为淋巴瘤生物标志物和分子靶点的研究进展
- Author:
Yanrong WANG
1
;
Xiaohong HAN
;
Yuankai SHI
Author Information
1. 国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院内科 抗肿瘤分子靶向药物临床研究北京市重点实验室
- Keywords:
Systemic inflammatory response syndrome;
Lymphoma;
Tumor markers,biological;
Molecular targeted therapy
- From:
Journal of Leukemia & Lymphoma
2019;28(8):501-505
- CountryChina
- Language:Chinese
-
Abstract:
The inflammatory response is involved in the development of most diseases. In recent years, tumor associated inflammatory response in tumor microenvironment has been paid more attention. Inflammation promotes the progress of lymphoma, and the growth and proliferation of lymphoma cells also depend on the inflammatory tumor microenvironment. Inflammatory response plays an important role in the development and treatment of lymphoma. Inflammatory cytokines are main types of inflammatory mediators, their expression levels reflect the inflammatory response state of the body, and have potential to be biomarkers and molecular targets of lymphoma.
